-
PurposeExpresses GST-tagged mClover3-anti-rabbit-IgG(Fc)-nanobody in E. coli cells.
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 138129 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGEX6P1
-
Backbone manufacturerGE healthcare
- Backbone size w/o insert (bp) 5000
- Total vector size (bp) 6061
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namemClover3-anti-rabbit-IgG(Fc)-nanobody
-
Alt nameTP955
-
SpeciesVicugna pacos
-
Insert Size (bp)1095
-
Tag
/ Fusion Protein
- GST (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CGTATTGAAGCTATCCCAC
- 3′ sequencing primer CGGCATCCGCTTACAGAC (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAddgene plasmid #74253 and #104164.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGEX6P1-mClover3-anti-rabbit-IgG(Fc)-nanobody was a gift from Kazuhisa Nakayama (Addgene plasmid # 138129 ; http://n2t.net/addgene:138129 ; RRID:Addgene_138129) -
For your References section:
Practical method for super-resolution imaging of primary cilia and centrioles by expansion microscopy using an amplibody for fluorescence signal amplification. Katoh Y, Chiba S, Nakayama K. Mol Biol Cell. 2020 Jul 29:mbcE20040250. doi: 10.1091/mbc.E20-04-0250. 10.1091/mbc.E20-04-0250 PubMed 32726175